Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 193

1.

Surveillance systems for healthcare-associated infection in high and upper-middle income countries: A scoping review.

Takaya S, Hayakawa K, Matsunaga N, Moriyama Y, Katanami Y, Tajima T, Tanaka C, Kimura Y, Saito S, Kusama Y, Morioka S, Fujitomo Y, Ohmagari N.

J Infect Chemother. 2020 Feb 17. pii: S1341-321X(20)30008-8. doi: 10.1016/j.jiac.2020.01.001. [Epub ahead of print] Review.

PMID:
32081645
2.

Epidemiology of antimicrobial use among nursing homes in Japan, 2016: A pilot study.

Ishikane M, Kusama Y, Tanaka C, Hayakawa K, Kuwahara T, Ohmagari N.

Jpn J Infect Dis. 2020 Jan 31. doi: 10.7883/yoken.JJID.2019.476. [Epub ahead of print]

3.

A nationwide questionnaire survey of clinic doctors on antimicrobial stewardship in Japan.

Gu Y, Fujitomo Y, Soeda H, Nakahama C, Hasegawa N, Maesaki S, Maeda M, Matsumoto T, Miyairi I, Ohmagari N.

J Infect Chemother. 2020 Feb;26(2):149-156. doi: 10.1016/j.jiac.2019.12.005. Epub 2019 Dec 24.

PMID:
31879188
4.

Varicella in Adult Foreigners at a Referral Hospital, Central Tokyo, Japan, 2012-2016.

Takaya S, Kutsuna S, Katanami Y, Yamamoto K, Takeshita N, Hayakawa K, Kato Y, Kanagawa S, Ohmagari N.

Emerg Infect Dis. 2020 Jan;26(1):114-117. doi: 10.3201/eid2601.170565.

5.

Comparison of penicillins (penicillin G and ampicillin) and cefazolin as a definitive therapy against penicillin-susceptible Staphylococcus aureus (PSSA) bacteremia in Japan: a retrospective cohort study.

Moriyama Y, Ishikane M, Mezaki K, Ohmagari N.

J Infect Chemother. 2019 Dec 7. pii: S1341-321X(19)30341-1. doi: 10.1016/j.jiac.2019.10.023. [Epub ahead of print]

PMID:
31822451
6.

National trend of blood-stream infection attributable deaths caused by Staphylococcus aureus and Escherichia coli in Japan.

Tsuzuki S, Matsunaga N, Yahara K, Gu Y, Hayakawa K, Hirabayashi A, Kajihara T, Sugai M, Shibayama K, Ohmagari N.

J Infect Chemother. 2019 Dec 1. pii: S1341-321X(19)30335-6. doi: 10.1016/j.jiac.2019.10.017. [Epub ahead of print]

7.

Adherence to personal protective equipment use among nurses in Japanese tertiary care hospitals: what determines variability?

Morioka S, Tajima T, Sugiki Y, Hayakawa K, Ohmagari N.

J Hosp Infect. 2019 Nov 29. pii: S0195-6701(19)30489-X. doi: 10.1016/j.jhin.2019.11.019. [Epub ahead of print]

PMID:
31790746
8.

Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae.

Hayakawa K, Nakano R, Hase R, Shimatani M, Kato H, Hasumi J, Doi A, Sekiya N, Nei T, Okinaka K, Kasahara K, Kurai H, Nagashima M, Miyoshi-Akiyama T, Kakuta R, Yano H, Ohmagari N.

J Antimicrob Chemother. 2020 Mar 1;75(3):697-708. doi: 10.1093/jac/dkz501.

PMID:
31789374
9.

Case Report: Two Cases of Acute Q Fever from the Same Family Who Returned from Malawi to Japan.

Matsui T, Nakamoto T, Hayakawa K, Yamamoto K, Nakamura K, Kutsuna S, Nagashima M, Toriniwa H, Komiya T, Ohmagari N.

Am J Trop Med Hyg. 2019 Dec;101(6):1263-1264. doi: 10.4269/ajtmh.19-0544.

PMID:
31674302
10.

IMP-68, a Novel IMP-Type Metallo-β-Lactamase in Imipenem-Susceptible Klebsiella pneumoniae.

Kubota H, Suzuki Y, Okuno R, Uchitani Y, Ariyoshi T, Takemura N, Mihara F, Mezaki K, Ohmagari N, Matsui M, Suzuki S, Sekizuka T, Kuroda M, Yokoyama K, Sadamasu K.

mSphere. 2019 Oct 30;4(5). pii: e00736-19. doi: 10.1128/mSphere.00736-19.

11.

Eight-Year Experience of Antimicrobial Stewardship Program and the Trend of Carbapenem Use at a Tertiary Acute-Care Hospital in Japan-The Impact of Postprescription Review and Feedback.

Akazawa T, Kusama Y, Fukuda H, Hayakawa K, Kutsuna S, Moriyama Y, Ohashi H, Tamura S, Yamamoto K, Hara R, Shigeno A, Ota M, Ishikane M, Tokita S, Terakado H, Ohmagari N.

Open Forum Infect Dis. 2019 Sep 5;6(10):ofz389. doi: 10.1093/ofid/ofz389. eCollection 2019 Oct.

12.

Longitudinal trends of and factors associated with inappropriate antibiotic prescribing for non-bacterial acute respiratory tract infection in Japan: A retrospective claims database study, 2012-2017.

Kimura Y, Fukuda H, Hayakawa K, Ide S, Ota M, Saito S, Ishikane M, Kusama Y, Matsunaga N, Ohmagari N.

PLoS One. 2019 Oct 16;14(10):e0223835. doi: 10.1371/journal.pone.0223835. eCollection 2019.

13.

Relationship between drug formulary and frequently used cephalosporins, macrolides and quinolones in Japanese hospitals.

Kusama Y, Muraki Y, Mochizuki T, Kurai H, Gu Y, Ohmagari N.

J Infect Chemother. 2020 Feb;26(2):211-215. doi: 10.1016/j.jiac.2019.08.013. Epub 2019 Sep 19.

PMID:
31543436
14.

Reply to "Initial Narrow- or Broad-spectrum Treatment for Meningoencephalitis".

Tanabe S, Kutsuna S, Tsuboi M, Takeshita N, Hayakawa K, Ohmagari N.

Intern Med. 2020 Feb 1;59(3):465. doi: 10.2169/internalmedicine.3743-19. Epub 2019 Sep 18. No abstract available.

15.

GATA2 mutation underlies hemophagocytic lymphohistiocytosis in an adult with primary cytomegalovirus infection.

Suzuki T, Takaya S, Kunimatsu J, Kutsuna S, Hayakawa K, Shibata H, Yasumi T, Ohmagari N.

J Infect Chemother. 2020 Feb;26(2):252-256. doi: 10.1016/j.jiac.2019.07.002. Epub 2019 Jul 23.

PMID:
31350183
16.

What is the impact of the change in DDD of amoxicillin and amoxicillin combined with β-lactamase inhibitors on nationwide surveillance of antimicrobial use?

Kusama Y, Ishikane M, Tanaka C, Tsuzuki S, Muraki Y, Ohmagari N.

J Antimicrob Chemother. 2019 Oct 1;74(10):3119-3121. doi: 10.1093/jac/dkz305. No abstract available.

PMID:
31314083
17.

Anterior Tibial Artery Hemorrhaging Mimicking Necrotizing Fasciitis.

Morioka S, Hashikura K, Nishio H, Ohmagari N.

Intern Med. 2019 Oct 15;58(20):3065. doi: 10.2169/internalmedicine.2919-19. Epub 2019 Jun 27. No abstract available.

18.

Isolation of OXA-181 Carbapenemase-Producing Escherichia coli and OXA-232 Carbapenemase-Producing Klebsiella pneumoniae from a Pregnant Woman Returning to Japan from India.

Tamura S, Hayakawa K, Miyoshi-Akiyama T, Nakanishi M, Yano T, Shimoya K, Sugiki Y, Mezaki K, Ohmagari N.

Jpn J Infect Dis. 2019 Jul 24;72(4):281-283. doi: 10.7883/yoken.JJID.2018.432. Epub 2019 May 31. No abstract available.

19.

Rabies post-exposure prophylactic vaccination for returning travelers to Japan.

Yamamoto K, Ujiie M, Noguchi A, Kato Y, Fujiya Y, Mawatari M, Kutsuna S, Takeshita N, Hayakawa K, Kanagawa S, Inoue S, Morikawa S, Ohmagari N.

J Infect Chemother. 2019 Dec;25(12):931-935. doi: 10.1016/j.jiac.2019.05.004. Epub 2019 May 30.

PMID:
31155449
20.

Dengue Virus Type 2 Infection in a Traveler Returning from Saudi Arabia to Japan.

Matsui T, Kinoshita N, Maeki T, Kutsuna S, Nakamura K, Nakamoto T, Ishikane M, Tajima S, Kato F, Taniguchi S, Lim CK, Saijo M, Ohmagari N.

Jpn J Infect Dis. 2019 Sep 19;72(5):340-342. doi: 10.7883/yoken.JJID.2018.537. Epub 2019 Apr 26.

21.

Regional Variation of Antimicrobial Use in Japan from 2013-2016, as Estimated by the Sales Data.

Kusama Y, Ishikane M, Tanaka C, Kimura Y, Yumura E, Hayakawa K, Muraki Y, Yamasaki D, Tanabe M, Ohmagari N.

Jpn J Infect Dis. 2019 Sep 19;72(5):326-329. doi: 10.7883/yoken.JJID.2018.417. Epub 2019 Apr 26.

22.

The impact of infectious disease consultation in candidemia in a tertiary care hospital in Japan over 12 years.

Ishikane M, Hayakawa K, Kutsuna S, Takeshita N, Ohmagari N.

PLoS One. 2019 Apr 25;14(4):e0215996. doi: 10.1371/journal.pone.0215996. eCollection 2019.

23.

The Authors' Reply to "Both Macro and Micro Filarial Treatment May Be Necessary to Treat Hydrocele Due to a Wuchereria bancrofti Infection".

Takaya S, Kutsuna S, Kato Y, Ohmagari N.

Intern Med. 2019 Aug 15;58(16):2425. doi: 10.2169/internalmedicine.2840-19. Epub 2019 Apr 17. No abstract available.

24.

Meningoencephalitis Caused by a Campylobacter fetus in a Patient with Chronic Alcoholism.

Tanabe S, Kutsuna S, Tsuboi M, Takeshita N, Hayakawa K, Ohmagari N.

Intern Med. 2019 Aug 1;58(15):2247-2250. doi: 10.2169/internalmedicine.1486-18. Epub 2019 Mar 28.

25.

Age-related differences in clinical characteristics of invasive group G streptococcal infection: Comparison with group A and group B streptococcal infections.

Fujiya Y, Hayakawa K, Gu Y, Yamamoto K, Mawatari M, Kutsuna S, Takeshita N, Kato Y, Kanagawa S, Ohmagari N.

PLoS One. 2019 Mar 7;14(3):e0211786. doi: 10.1371/journal.pone.0211786. eCollection 2019.

26.

Calcium Pyrophosphate Deposition Disease Involving a Lumbar Facet Joint Following Urinary Tract Infection.

Ujihara T, Yamamoto K, Kitaura T, Katanami Y, Kutsuna S, Takeshita N, Hayakawa K, Ohmagari N.

Intern Med. 2019 Jun 15;58(12):1787-1789. doi: 10.2169/internalmedicine.2099-18. Epub 2019 Feb 25.

27.

Helicobacter cinaedi Hepatic Cyst Infection with Bacteremia.

Suzuki T, Kutsuna S, Tsuboi M, Ota M, Hayakawa K, Ohmagari N.

Emerg Infect Dis. 2019 Mar;25(3):603-604. doi: 10.3201/eid2503.180936.

28.

A case of Klebsiella pneumoniae spondylitis and bacteremia potentially due to inflammation around a fecalith.

Inagaki A, Moriyama Y, Morioka S, Wakimoto Y, Shida Y, Ohmagari N.

J Infect Chemother. 2019 Jun;25(6):470-472. doi: 10.1016/j.jiac.2019.01.001. Epub 2019 Feb 14.

PMID:
30773382
29.

Imported Malaria at a Referral Hospital in Tokyo from 2005 to 2016: Clinical Experience and Challenges in a Non-Endemic Setting.

Takaya S, Kato Y, Katanami Y, Yamamoto K, Kutsuna S, Takeshita N, Hayakawa K, Kanagawa S, Komaki-Yasuda K, Kano S, Ohmagari N.

Am J Trop Med Hyg. 2019 Apr;100(4):828-834. doi: 10.4269/ajtmh.18-0722.

30.

Clinical trial with unlicensed yellow fever vaccine in Japan.

Ujiie M, Terada M, Kobayakawa M, Ohmagari N.

J Travel Med. 2019 Sep 2;26(6). pii: tay151. doi: 10.1093/jtm/tay151. No abstract available.

PMID:
30657930
31.

Comparison of knowledge to antimicrobial stewardship institution policies targeting Staphylococcus aureus bacteremia and candidemia between medical doctors and pharmacists in an academic teaching hospital in Japan.

Moriyama Y, Ishikane M, Hayakawa K, Yamamoto K, Akazawa T, Sugiki Y, Ohmagari N.

J Infect Chemother. 2019 May;25(5):396-399. doi: 10.1016/j.jiac.2018.11.006. Epub 2018 Dec 1.

PMID:
30509484
32.

Hydrocele due to Wuchereria bancrofti Infection.

Takaya S, Kutsuna S, Kato Y, Ohmagari N.

Intern Med. 2019 Mar 15;58(6):897. doi: 10.2169/internalmedicine.0871-18. Epub 2018 Nov 19. No abstract available.

33.

Mild encephalitis/encephalopathy with a reversible splenial lesion due to Plasmodium falciparum malaria: a case report.

Mawatari M, Kobayashi T, Yamamoto S, Takeshita N, Hayakawa K, Kutsuna S, Ohmagari N, Noguchi T, Kato Y.

Trop Med Health. 2018 Nov 6;46:37. doi: 10.1186/s41182-018-0119-4. eCollection 2018.

34.

Public knowledge and perception about antimicrobials and antimicrobial resistance in Japan: A national questionnaire survey in 2017.

Kamata K, Tokuda Y, Gu Y, Ohmagari N, Yanagihara K.

PLoS One. 2018 Nov 5;13(11):e0207017. doi: 10.1371/journal.pone.0207017. eCollection 2018.

35.

Assessment of Bacteremia in a Large Tertiary Care Hospital in Northern Vietnam: a Single-Center Retrospective Surveillance Study.

Takeshita N, Anh NQ, Phuong DM, Thanh DV, Thuy PP, Huong MTL, Takahashi M, Ohmagari N.

Jpn J Infect Dis. 2019 Mar 25;72(2):118-120. doi: 10.7883/yoken.JJID.2018.163. Epub 2018 Oct 31.

36.

Comparison of the epidemiology and microbiology of peripheral line- and central line-associated bloodstream infections.

Tsuboi M, Hayakawa K, Mezaki K, Katanami Y, Yamamoto K, Kutsuna S, Takeshita N, Ohmagari N.

Am J Infect Control. 2019 Feb;47(2):208-210. doi: 10.1016/j.ajic.2018.08.016. Epub 2018 Oct 15.

PMID:
30337129
37.

Real-time PCR investigation of the prevalence of Fusobacterium necrophorum in patients with pharyngitis in Japan.

Hayakawa K, Nagashima M, Kanehisa E, Watanabe R, Kunimatsu J, Ohta K, Mutoh Y, Hashimoto T, Katanami Y, Yamamoto K, Kutsuna S, Tayama N, Ohmagari N.

J Infect Chemother. 2018 Dec;24(12):969-974. doi: 10.1016/j.jiac.2018.09.008. Epub 2018 Oct 11.

PMID:
30316745
38.

Case Report: Plasmodium knowlesi Infection with Rhabdomyolysis in a Japanese Traveler to Palawan, the Philippines.

Takaya S, Kutsuna S, Suzuki T, Komaki-Yasuda K, Kano S, Ohmagari N.

Am J Trop Med Hyg. 2018 Oct;99(4):967-969. doi: 10.4269/ajtmh.18-0348.

39.

Wohlfahrtiimonas chitiniclastica Bacteremia Hospitalized Homeless Man with Squamous Cell Carcinoma.

Katanami Y, Kutsuna S, Nagashima M, Takaya S, Yamamoto K, Takeshita N, Hayakawa K, Kato Y, Kanagawa S, Ohmagari N.

Emerg Infect Dis. 2018 Sep;24(9):1746-1748. doi: 10.3201/eid2409.170080.

40.

Development and efficacy of a clinician-targeted refresher course for treating nonpneumonia respiratory tract infections.

Yamamoto S, Gu Y, Fujitomo Y, Kanai N, Yamahata Y, Saito H, Hashimoto T, Ohmagari N.

J Gen Fam Med. 2018 Jun 21;19(4):127-132. doi: 10.1002/jgf2.183. eCollection 2018 Jul.

41.

Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains.

Hamasuna R, Le PT, Kutsuna S, Furubayashi K, Matsumoto M, Ohmagari N, Fujimoto N, Matsumoto T, Jensen JS.

PLoS One. 2018 Jun 8;13(6):e0198355. doi: 10.1371/journal.pone.0198355. eCollection 2018.

42.

Fusobacterium necrophorum Subsp. funduliforme in Tonsils from Various Patient Populations in Japan.

Hayakawa K, Nagashima M, Ohta K, Ohmagari N, Tayama N.

Jpn J Infect Dis. 2018 Sep 21;71(5):365-367. doi: 10.7883/yoken.JJID.2018.061. Epub 2018 May 31.

43.

Clinical characteristics and epidemiology of intestinal tapeworm infections over the last decade in Tokyo, Japan: A retrospective review.

Tsuboi M, Hayakawa K, Yamasaki H, Katanami Y, Yamamoto K, Kutsuna S, Takeshita N, Kanagawa S, Ohmagari N, Kato Y.

PLoS Negl Trop Dis. 2018 Feb 20;12(2):e0006297. doi: 10.1371/journal.pntd.0006297. eCollection 2018 Feb.

44.

A novel PCR-based system for the detection of four species of human malaria parasites and Plasmodium knowlesi.

Komaki-Yasuda K, Vincent JP, Nakatsu M, Kato Y, Ohmagari N, Kano S.

PLoS One. 2018 Jan 25;13(1):e0191886. doi: 10.1371/journal.pone.0191886. eCollection 2018.

45.

Cryptococcus gattii genotype VGIIa infection imported from Vancouver Island to Japan.

Kitaura T, Takahashi M, Umeyama T, Takeshita N, Katanami Y, Takaya S, Yamamoto K, Kutsuna S, Hayakawa K, Kato Y, Yamauchi T, Narita Y, Miyazaki Y, Ohmagari N.

J Infect Chemother. 2018 Jul;24(7):573-575. doi: 10.1016/j.jiac.2017.12.014. Epub 2018 Jan 17.

PMID:
29352650
46.

Adherence to contact precautions by different types of healthcare workers through video monitoring in a tertiary hospital.

Katanami Y, Hayakawa K, Shimazaki T, Sugiki Y, Takaya S, Yamamoto K, Kutsuna S, Kato Y, Ohmagari N.

J Hosp Infect. 2018 Sep;100(1):70-75. doi: 10.1016/j.jhin.2018.01.001. Epub 2018 Jan 6.

PMID:
29317259
47.

Infective Endarteritis due to Staphylococcus capitis.

Yamamoto K, Ohmagari N.

Intern Med. 2018 Apr 15;57(8):1185. doi: 10.2169/internalmedicine.0070-17. Epub 2017 Dec 27. No abstract available.

48.
49.

Case Report: Reversible Cerebral Vasoconstriction Syndrome in Cerebral Malaria.

Yamamoto K, Kato Y, Shinohara K, Kutsuna S, Takeshita N, Hayakawa K, Iwagami M, Kano S, Watanabe S, Ohmagari N.

Am J Trop Med Hyg. 2018 Feb;98(2):505-507. doi: 10.4269/ajtmh.17-0665. Epub 2017 Dec 14.

50.

Emergence and Spread of Epidemic Multidrug-Resistant Pseudomonas aeruginosa.

Miyoshi-Akiyama T, Tada T, Ohmagari N, Viet Hung N, Tharavichitkul P, Pokhrel BM, Gniadkowski M, Shimojima M, Kirikae T.

Genome Biol Evol. 2017 Dec 1;9(12):3238-3245. doi: 10.1093/gbe/evx243.

Supplemental Content

Loading ...
Support Center